Skip to content
healthcare.dev

doxorubicin hydrochloride

NDC 68001-707, doxorubicin hydrochloride, injection, suspension, liposomal, from BluePoint Laboratories.

Product NDC
68001-707
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219199
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-707 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
68001-707-26680010707261 VIAL, SINGLE-DOSE in 1 CARTON (68001-707-26) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/55889588-c5f1-d9bc-e063-6294a90a5791

Use it

Look up 68001-707 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-707 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-707. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.